Element Biosciences develops tools for genetic analysis, designed to cater to the research and diagnostic markets. The company's technology involves a high-performance, modular DNA sequencing platform that provides high-quality data and flexible workflows. This makes next-generation sequencing technology more accessible, empowering medical researchers to enhance and advance their research.

Investors Include:

Foresite Capital Management, Meritech Capital Partners, Fusion Fund, Alexandria Venture Investments, Logos Capital, Janus Henderson Investors, JS Capital Management, Venrock, RA Capital Management, T. Rowe Price, Morgan Stanley, Fidelity Management & Research.

Own Element Biosciences stock or options?

Get an instant valuation

Completely free
100% confidential & secure
Takes less than a minute

What company do you own stock or options in?

How many shares or options do you own?

100% private & secure